172 related articles for article (PubMed ID: 37558923)
1. Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program.
Park J; Shim JK; Lee M; Kim D; Yoon SJ; Moon JH; Kim EH; Park JY; Chang JH; Kang SG
Br J Cancer; 2023 Oct; 129(7):1061-1070. PubMed ID: 37558923
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor.
Park J; Lee D; Shim JK; Yoon SJ; Moon JH; Kim EH; Chang JH; Lee SJ; Kang SG
Yonsei Med J; 2023 Mar; 64(3):157-166. PubMed ID: 36825341
[TBL] [Abstract][Full Text] [Related]
3. Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres.
Yoon SJ; Son HY; Shim JK; Moon JH; Kim EH; Chang JH; Teo WY; Kim SH; Park SW; Huh YM; Kang SG
J Transl Med; 2020 Dec; 18(1):482. PubMed ID: 33317554
[TBL] [Abstract][Full Text] [Related]
4. Annexin A2-STAT3-Oncostatin M receptor axis drives phenotypic and mesenchymal changes in glioblastoma.
Matsumoto Y; Ichikawa T; Kurozumi K; Otani Y; Fujimura A; Fujii K; Tomita Y; Hattori Y; Uneda A; Tsuboi N; Kaneda K; Makino K; Date I
Acta Neuropathol Commun; 2020 Apr; 8(1):42. PubMed ID: 32248843
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of STAT3 gene expression in patients with glioblastoma tumors: a study from Western India.
Trivedi T; Panchal K; Bhalala N; Trivedi P
J Egypt Natl Canc Inst; 2022 Jul; 34(1):30. PubMed ID: 35844028
[TBL] [Abstract][Full Text] [Related]
6. STAT6 expression in glioblastoma promotes invasive growth.
Merk BC; Owens JL; Lopes MB; Silva CM; Hussaini IM
BMC Cancer; 2011 May; 11():184. PubMed ID: 21595984
[TBL] [Abstract][Full Text] [Related]
7. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
[TBL] [Abstract][Full Text] [Related]
8. The interference of Notch1 target Hes1 affects cell growth, differentiation and invasiveness of glioblastoma stem cells through modulation of multiple oncogenic targets.
Cenciarelli C; Marei HE; Zonfrillo M; Casalbore P; Felsani A; Giannetti S; Trevisi G; Althani A; Mangiola A
Oncotarget; 2017 Mar; 8(11):17873-17886. PubMed ID: 28157712
[TBL] [Abstract][Full Text] [Related]
9. TROY signals through JAK1-STAT3 to promote glioblastoma cell migration and resistance.
Ding Z; Kloss JM; Tuncali S; Tran NL; Loftus JC
Neoplasia; 2020 Sep; 22(9):352-364. PubMed ID: 32629176
[TBL] [Abstract][Full Text] [Related]
10. GBP2 enhances glioblastoma invasion through Stat3/fibronectin pathway.
Yu S; Yu X; Sun L; Zheng Y; Chen L; Xu H; Jin J; Lan Q; Chen CC; Li M
Oncogene; 2020 Jul; 39(27):5042-5055. PubMed ID: 32518375
[TBL] [Abstract][Full Text] [Related]
11. Suppression of LIM Kinase 1 and LIM Kinase 2 Limits Glioblastoma Invasion.
Chen J; Ananthanarayanan B; Springer KS; Wolf KJ; Sheyman SM; Tran VD; Kumar S
Cancer Res; 2020 Jan; 80(1):69-78. PubMed ID: 31641031
[TBL] [Abstract][Full Text] [Related]
12. C5α secreted by tumor mesenchymal stem-like cells mediates resistance to 5-aminolevulinic acid-based photodynamic therapy against glioblastoma tumorspheres.
Park J; Oh SJ; Shim JK; Ji YB; Moon JH; Kim EH; Huh YM; Suh JS; Chang JH; Lee SJ; Kang SG
J Cancer Res Clin Oncol; 2023 Jul; 149(8):4391-4402. PubMed ID: 36107247
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of CD97 confers an invasive phenotype in glioblastoma cells and is associated with decreased survival of glioblastoma patients.
Safaee M; Clark AJ; Oh MC; Ivan ME; Bloch O; Kaur G; Sun MZ; Kim JM; Oh T; Berger MS; Parsa AT
PLoS One; 2013; 8(4):e62765. PubMed ID: 23658650
[TBL] [Abstract][Full Text] [Related]
14. Combined treatment with 2'-hydroxycinnamaldehyde and temozolomide suppresses glioblastoma tumorspheres by decreasing stemness and invasiveness.
Jeong H; Park J; Shim JK; Lee JE; Kim NH; Kim HS; Chang JH; Yook JI; Kang SG
J Neurooncol; 2019 May; 143(1):69-77. PubMed ID: 30887242
[TBL] [Abstract][Full Text] [Related]
15. ZWINT: A potential therapeutic biomarker in patients with glioblastoma correlates with cell proliferation and invasion.
Yang L; Han N; Zhang X; Zhou Y; Chen R; Zhang M
Oncol Rep; 2020 Jun; 43(6):1831-1844. PubMed ID: 32323832
[TBL] [Abstract][Full Text] [Related]
16. Regulation of bioenergetics through dual inhibition of aldehyde dehydrogenase and mitochondrial complex I suppresses glioblastoma tumorspheres.
Park J; Shim JK; Kang JH; Choi J; Chang JH; Kim SY; Kang SG
Neuro Oncol; 2018 Jun; 20(7):954-965. PubMed ID: 29294080
[TBL] [Abstract][Full Text] [Related]
17. CBF1 is clinically prognostic and serves as a target to block cellular invasion and chemoresistance of EMT-like glioblastoma cells.
Maciaczyk D; Picard D; Zhao L; Koch K; Herrera-Rios D; Li G; Marquardt V; Pauck D; Hoerbelt T; Zhang W; Ouwens DM; Remke M; Jiang T; Steiger HJ; Maciaczyk J; Kahlert UD
Br J Cancer; 2017 Jun; 117(1):102-112. PubMed ID: 28571041
[TBL] [Abstract][Full Text] [Related]
18. Over-expressed lncRNA HOTAIRM1 promotes tumor growth and invasion through up-regulating HOXA1 and sequestering G9a/EZH2/Dnmts away from the HOXA1 gene in glioblastoma multiforme.
Li Q; Dong C; Cui J; Wang Y; Hong X
J Exp Clin Cancer Res; 2018 Oct; 37(1):265. PubMed ID: 30376874
[TBL] [Abstract][Full Text] [Related]
19. Glioblastoma Exhibits Inter-Individual Heterogeneity of TSPO and LAT1 Expression in Neoplastic and Parenchymal Cells.
Cai L; Kirchleitner SV; Zhao D; Li M; Tonn JC; Glass R; Kälin RE
Int J Mol Sci; 2020 Jan; 21(2):. PubMed ID: 31963507
[TBL] [Abstract][Full Text] [Related]
20. CtBP2 interacts with ZBTB18 to promote malignancy of glioblastoma.
Chen L; Wang L; Qin J; Wei DS
Life Sci; 2020 Dec; 262():118477. PubMed ID: 32971103
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]